Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 690 participants.
Also called NCT01962545
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 690 participants
- Sponsor
- Registry
-
NCT01962545
-
- Other papers using this trial's data
- Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01962545. Randomized; no masking; primary purpose treatment. Start 2013-11-05 (actual); primary completion 2017-05-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
- Acronym
- OAC-ALONE
- Condition
- Atrial Fibrillation
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- OAC alone
- Lead sponsor
- Satoshi Shizuta
- Collaborator
- Research Institute for Production Development
- Collaborator
- Daiichi Sankyo Co., Ltd.
Record details
- Record id
cardio:ct-nct01962545- Content hash
d3e3d76e93eeedff9fc5ba37a9bed089be67e5e2a9391d9b61ac2a7dccf264a4